{"schema_version":"secwatch.filing_event.v1","accession":"0001040130-25-000034","form_type":"8-K","ticker":"PETS","cik":"0001040130","company_name":"PETMED EXPRESS INC","filed_at":"2025-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.260692+00:00","generated_at":"2026-05-19T05:56:49.821362+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"PetMed Express prelim Q4 sales $51-53M vs $66.5M; net loss widens to $10M; delays 10-K","bullets":["Q4 net sales estimated $51.1-53.1M (down ~21% YoY); net loss $9.9-10.4M vs $5.0M prior year.","FY2025 net sales $231.6-233.6M (down ~17% YoY); FY net loss $4.5-5.0M vs $7.5M prior year.","FY net loss includes $8.7M non-cash benefit from executive departure and $6.4M deferred tax asset valuation allowance.","Cash position $54.7M with no debt as of March 31, 2025.","Company filed Form 12b-25; expects to file annual 10-K by July 1, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001040130-25-000034","json":"https://secwatch.observer/filing/0001040130-25-000034.json","markdown":"https://secwatch.observer/filing/0001040130-25-000034.md","text":"https://secwatch.observer/filing/0001040130-25-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000104013025000034/0001040130-25-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000104013025000034/pets-20250616.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T05:56:49.821362+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}